A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept

NCT06971185 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndromes (MDS)

Interventions

DRUG: Luspatercept
DRUG: Erythropoiesis-stimulating agent (ESA)

Sponsor

Bristol-Myers Squibb